MDL 29,913

MDL 29913 acts as selective antagonist of NK2 tachykinin receptor. It is used for the treatment of IBS.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: R1071

CAS No:135721-56-1

Synonyms/Alias:1,4,7,10,13,16-Hexaazacyclooctadecane, Cyclic Peptide Deriv.; N-​(2-​Amino-​4-​methylpentyl)​-​N-​methyl-​L-​leucyl-​L-​glutaminyl-​L-​tryptophyl-​L-​phenylalanylglycine (5→1)​-​Lactam

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C40H56N8O6
M.W/Mr.
745
Sequence
QWFGLL(Modifications: Leu-5 - Leu-6 = Leu-CH2N(CH3)-Leu, Cyclized)
Labeling Target
NK2 tachykinin receptor
Appearance
White lyophilised solid
Purity
>97%
Activity
Antagonist
Long-term Storage Conditions
Soluble in water
InChI
InChI=1S/C40H56N8O6/c1-25(2)19-29(41)24-48(5)35(20-26(3)4)40(54)45-32(15-16-36(42)50)38(52)47-34(22-28-23-44-31-14-10-9-13-30(28)31)39(53)46-33(37(51)43-17-18-49)21-27-11-7-6-8-12-27/h6-14,17-18,23,25-26,29,32-35,44H,15-16,19-22,24,41H2,1-5H3,(H2,42,50)(H,45,54
InChI Key
DBIVSFCCTOEQTP-CITGXELPSA-N
Isomeric SMILES
CC(C)CC(N)CN(C)[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc3ccccc3)C(=O)N=CC=O
BoilingPoint
N/A
Melting Point
N/A

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Synthesis ServicesCustom Conjugation ServicePeptide Nucleic Acids SynthesisEpitope Mapping ServicescGMP Peptide ServicePeptide Analysis ServicesPeptide CDMOPeptide Modification Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers